Aspire Net Receivables from 2010 to 2025
| ASBP Stock | 0.09 0 2.16% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 32.9 K | Current Value 29.2 K | Quarterly Volatility 2 K |
Check Aspire BioPharma, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspire BioPharma,'s main balance sheet or income statement drivers, such as Tax Provision of 443, Interest Expense of 936.2 K or Selling General Administrative of 573.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aspire financial statements analysis is a perfect complement when working with Aspire BioPharma, Valuation or Volatility modules.
Check out the analysis of Aspire BioPharma, Correlation against competitors. Pair Trading with Aspire BioPharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspire BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspire BioPharma, will appreciate offsetting losses from the drop in the long position's value.Moving together with Aspire Stock
Moving against Aspire Stock
The ability to find closely correlated positions to Aspire BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspire BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspire BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspire BioPharma, to buy it.
The correlation of Aspire BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspire BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspire BioPharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspire BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma,'s price analysis, check to measure Aspire BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma, is operating at the current time. Most of Aspire BioPharma,'s value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma,'s price. Additionally, you may evaluate how the addition of Aspire BioPharma, to your portfolios can decrease your overall portfolio volatility.